title: Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.
abstract: Micellar delivery systems smaller than 100 nm can be readily prepared. While micelles allow a great depth of tissue penetration for targeted drug delivery, they usually disintegrate rapidly in the body. Thus, sustained drug delivery from micellar nanocarriers is a challenge. This article summarizes various key strategies and underlying principles for sustained drug delivery using micellar nanocarriers. Comparisons are made with other competing delivery systems such as polymeric microparticles and nanoparticles. Amphiphilic molecules self-assemble in appropriate liquid media to form nanoscale micelles. Strategies for sustained release nanomicellar carriers include use of prodrugs, drug polymer conjugates, novel polymers with low critical micellar concentration or of a reverse thermoresponsive nature, reverse micelles, multi-layer micelles with layer by layer assembly, polymeric films capable of forming micelles in vivo and micelle coats on a solid support. These new micellar systems are promising for sustained drug delivery.
authors.affiliation: Department of Pharmaceutical Sciences, University of Colorado Denver, 12700 E 19th Avenue, C238-P15, Aurora, CO 80045, USA.
authors.forename: Ruchit
authors.initials: R
authors.lastname: Trivedi
authors.forename: Uday B
authors.initials: UB
authors.lastname: Kompella
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008823:Micelles; D049329:Nanostructures / Q000737:chemistry*; D036103:Nanotechnology / Q000379:methods*
chemical_list: D008823:Micelles
references.citation: J Control Release. 2001 Jan 29;70(1-2):63-70
references.pmid: 11166408
references.citation: Macromol Biosci. 2009 May 13;9(5):515-24
references.pmid: 19089867
references.citation: J Control Release. 2006 May 1;112(1):57-63
references.pmid: 16516326
references.citation: Drug Deliv. 2001 Apr-Jun;8(2):99-106
references.pmid: 11400869
references.citation: BJU Int. 2009 Apr;103(7):978-86
references.pmid: 19007363
references.citation: Pharm Res. 2008 Jan;25(1):194-206
references.pmid: 17912488
references.citation: Pharmazie. 2008 Jun;63(6):446-52
references.pmid: 18604988
references.citation: Biomacromolecules. 2009 Jun 8;10(6):1532-9
references.pmid: 19361215
references.citation: Int J Pharm. 2009 Mar 18;369(1-2):170-5
references.pmid: 19028556
references.citation: Int J Cancer. 2009 Jun 1;124(11):2505-11
references.pmid: 19189401
references.citation: J Control Release. 2002 Feb 19;79(1-3):165-72
references.pmid: 11853928
references.citation: Colloids Surf B Biointerfaces. 2007 Apr 1;55(2):222-8
references.pmid: 17254755
references.citation: ACS Nano. 2008 Feb;2(2):386-92
references.pmid: 19206641
references.citation: Int J Pharm. 2009 May 21;373(1-2):100-6
references.pmid: 19429294
references.citation: J Control Release. 2000 Aug 10;68(2):167-74
references.pmid: 10925125
references.citation: Urology. 2003 Feb;61(2 Suppl 1):25-31
references.pmid: 12667884
references.citation: Macromol Biosci. 2008 Dec 8;8(12):1116-25
references.pmid: 18663739
references.citation: Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1192-201
references.pmid: 12601049
references.citation: J Biomed Mater Res A. 2007 May;81(2):326-33
references.pmid: 17120218
references.citation: Colloids Surf B Biointerfaces. 2008 Oct 1;66(1):26-33
references.pmid: 18583109
references.citation: Pharmacol Ther. 2006 Dec;112(3):630-48
references.pmid: 16815554
references.citation: Bioconjug Chem. 2001 Nov-Dec;12(6):917-23
references.pmid: 11716682
references.citation: J Control Release. 2008 Jul 2;129(1):33-40
references.pmid: 18456363
references.citation: J Invasive Cardiol. 2009 May;21(5):E77-80
references.pmid: 19411730
references.citation: Appl Environ Microbiol. 2006 Nov;72(11):7390-3
references.pmid: 16980422
references.citation: J Biomed Mater Res A. 2005 Dec 1;75(3):639-47
references.pmid: 16110497
references.citation: Angew Chem Int Ed Engl. 2008;47(30):5573-6
references.pmid: 18567037
references.citation: J Colloid Interface Sci. 2004 May 15;273(2):626-31
references.pmid: 15082402
references.citation: Biomacromolecules. 2009 Apr 13;10(4):732-41
references.pmid: 19235932
references.citation: J Control Release. 2009 Jun 19;136(3):187-95
references.pmid: 19289148
references.citation: J Biomed Mater Res B Appl Biomater. 2006 Apr;77(1):188-94
references.pmid: 16245284
references.citation: Bioconjug Chem. 2008 Nov 19;19(11):2231-8
references.pmid: 18847230
references.citation: Int J Antimicrob Agents. 2001 Sep;18(3):245-52
references.pmid: 11673037
references.citation: Int J Pharm. 2009 Mar 31;370(1-2):210-5
references.pmid: 19114094
references.citation: Biomaterials. 2009 May;30(13):2606-13
references.pmid: 19162320
references.citation: Biotechnol Annu Rev. 2001;7:87-129
references.pmid: 11686050
references.citation: Biomaterials. 2009 Jun;30(17):3100-9
references.pmid: 19342093
references.citation: Am J Vet Res. 2004 Jun;65(6):752-7
references.pmid: 15198214
references.citation: Cancer Res. 2003 Dec 15;63(24):8977-83
references.pmid: 14695216
references.citation: Macromol Biosci. 2009 May 13;9(5):456-63
references.pmid: 19089869
references.citation: Pharm Res. 2007 Oct;24(10):1944-53
references.pmid: 17530389
references.citation: Colloids Surf B Biointerfaces. 2007 Oct 15;60(1):117-24
references.pmid: 17644325
references.citation: Gene Ther. 2009 May;16(5):645-59
references.pmid: 19194480
references.citation: J Control Release. 2006 May 1;112(1):64-71
references.pmid: 16507325
references.citation: J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3095-101
references.pmid: 17048523
references.citation: Acta Pharm. 2009 Jun;59(2):133-44
references.pmid: 19564139
references.citation: Pharm Res. 2007 Jan;24(1):1-16
references.pmid: 17109211
references.citation: J Control Release. 2001 Jun 15;73(2-3):137-72
references.pmid: 11516494
references.citation: J Biomed Mater Res A. 2008 Sep 15;86(4):914-25
references.pmid: 18067189
references.citation: J Clin Oncol. 2008 May 20;26(15):2526-31
references.pmid: 18487569